UBS Group’s Adlai Nortye ANL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$846K Buy
122,261
+121,183
+11,241% +$810K ﹤0.01% 5677
2025
Q4
$1.53K Sell
1,078
-3,213
-75% -$4.87K ﹤0.01% 9547
2025
Q3
$7.72K Sell
4,291
-1,021
-19% -$1.66K ﹤0.01% 8704
2025
Q2
$7.81K Buy
5,312
+637
+14% +$1.16K ﹤0.01% 9001
2025
Q1
$9.4K Buy
4,675
+4,674
+467,400% +$10.1K ﹤0.01% 8691
2024
Q4
$3 Sell
1
-1,137
-100% -$2.58K ﹤0.01% 9846
2024
Q3
$2.26K Buy
+1,138
New +$3.33K ﹤0.01% 8473
2023
Q4
Sell
-585
Closed -$8.78K 9266
2023
Q3
$8.78K Buy
+585
New +$8.78K ﹤0.01% 7170

Other funds holding ANL

UBS Group's ANL Position: Q1 2026 in Review

UBS Group increased its Adlai Nortye (ANL) stake by 11,241% in Q1 2026, buying an estimated $810K and bringing the position to 122,261 shares worth $846K. The position accounts for ﹤0.01% of the portfolio, ranked #5677.

UBS Group first reported a position in ANL in Q3 2023 and has held it in 8 quarters since. 26 funds tracked by Wall St. Rank hold ANL as of Q1 2026.

  • UBS Group held 122,261 shares of Adlai Nortye worth $846K as of Q1 2026.
  • UBS Group bought 121,183 Adlai Nortye shares in Q1 2026, an estimated $810K.
  • Adlai Nortye made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5677 holding.
  • UBS Group first reported a position in Adlai Nortye in Q3 2023 and has held it in 8 quarters since.
  • 26 funds tracked by Wall St. Rank held Adlai Nortye as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.